Borres, Julia P.

HRN: 20-43-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2025
CEFUROXIME 750MG (VIAL)
06/26/2025
07/03/2025
IV
400mg
Q 8 Hours
T/C Bullous Impetigo
Waiting Final Action 
06/26/2025
MUPIROCIN 2%, 15G (TUBE)
06/26/2025
07/03/2025
TOPICAL
As Needed
Q 12
T/C Bullous Impetigo
Waiting Final Action 
06/26/2025
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
06/26/2025
07/03/2025
TOPICAL
As Needed
Q 12
T/C Bullous Impetigo
Waiting Final Action 
06/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/26/2025
07/03/2025
IV
100 Mg
Q 6 Hours
T/C Bullous Impetigo
Waiting Final Action 
06/30/2025
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
06/30/2025
07/07/2025
TOPICAL
15g; As Needed
Q12
TC Bullous Impetigo
Waiting Final Action 
06/30/2025
OXACILLIN 500MG (VIAL)
06/30/2025
07/07/2025
IV
375mg
Q6h
Cellulitis, Left Leg
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: